Clinical Trials

BREAKING NEWS FROM ASCO: Avelumab Results for Mesothelioma Treatment Released

Dr. Raffit Hassan of the National Cancer Institute, and former chair of the Mesothelioma Applied Research Foundation’s Science Advisory Board, announced results of the Phase 1 clinical trial of avelumab at the most recent ASCO (American Society of Clinical Oncology) meeting in Chicago.
Avelumab, an anti-PD-L1 antibody, works on the basis of boosting the immune system. […]

Read More